Research interests include clinical and translational research in new drug development, gastrointestinal and genito-urinary malignancies. Dr. Knox is also the Principal Investigator of trials in biliary, hepatocellular, esophageal and renal cell cancers.
Jennifer J Knox
Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.
J Surg Oncol. 2018 Feb;117(2):213-219
Comparison of Practice Guidelines, BRCAPRO, and Genetic Counselor Estimates to Identify Germline BRCA1 and BRCA2 Mutations in Pancreatic Cancer.
J Genet Couns. 2018 Feb 13;:
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC.
Ann Oncol. 2018 Jan 29;:
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer - Early Results from the COMPASS Trial.
Clin Cancer Res. 2017 Dec 29;:
Curr Probl Cancer. 2017 Nov 16;:
Curr Probl Cancer. 2017 Nov 14;:
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience.
Clin Colorectal Cancer. 2017 Oct 23;:
Surg Oncol Clin N Am. 2017 Oct;26(4):647-666
Mol Carcinog. 2017 Sep 11;:
Cell Immunol. 2017 Jul 11;:
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Associate Professor, Department of Medicine, University of Toronto
Chair, Kidney Disease Oriented Group, National Cancer Institute of Canada
Chair, Hepatobiliary Disease Oriented Group, National Cancer Institute of Canada